An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge

Virology Journal

Volumn 10, Issue , 2013, Pages

  Ma, Ji Hong ^a   Yang, Fu Ru ^a   Yu, Hai ^a   Zhou, Yan Jun ^a   Li, Guo Xin ^a   Huang, Meng ^a   Wen, Feng ^a   Tong, Guangzhi ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Influenza; Influenza A virus; M2e; Synthetic peptide vaccine

Indexed keywords

M2E MAP; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; VIRUS REPLICATION; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; CROSS PROTECTION; FEMALE; IMMUNOGLOBULIN G; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; SURVIVAL ANALYSIS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL LOAD; VIRAL MATRIX PROTEINS;

ANIMALIA; INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE; TETRA;

EID: 84880029888     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-227     Document Type: Article

References (27)

1. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines. Cox RJ, Brokstad KA, Ogra P, Scand J Immunol 2004 59 1365 3083
2. Universal influenza A vaccine: Optimization of M2-based constructs. De Filette M, Willy MJ, Birkett A, Lyons K, Schultz B, Tonkyro A, Resch S, Fiers W, Virology 2005 337 149 161 10.1016/j.virol.2005.04.004 15914228 (Pubitemid 40725448)
3. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Neumann, Nature 2009 459 931 939 10.1038/nature08157 19525932
4. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al. Science 2009 2009 325 197 201
5. Evolution and ecology of influenza A viruses. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y, Microbiol Rev 1992 56 152 179 1579108
6. Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Verhoeyen M, et al. Nature 1980 286 771 776 10.1038/286771a0 7402351
7. A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain. Posnett DN, McGrath H, Tam JP, J Biol Chem 1988 263 1719 1725 3276675 (Pubitemid 18052120)
8. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Tam JP, Proc Natl Acad Sci USA 1988 85 5409 5413 10.1073/pnas.85.15.5409 3399498
9. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. Zharikova D, Mozdzanowska K, Feng J, Zhang M, Gerhard W, J Virol 2005 79 6644 6654 10.1128/JVI.79.11.6644- 6654.2005 15890902 (Pubitemid 40677295)
10. Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice. Wolf AI, Mozdzanowska K, Williams KL, Singer D, Richter M, et al. PLoS One 2011 6 12 28445 10.1371/journal.pone.0028445 22180783
11. Design and validation of real-time Taqman fluorescence quantitative RT-PCR assay for rapid detection of type A influenza virus. Ma JH, Yu H, Zhou YJ, Li GX, Yan LP, Zhang SR, Wang B, Tong GZ, Chinese journal of animal infect diseases 2010 18 1 7
12. Influenza pandemics of the 20th century. Kilbourne ED, Emerg Infect Dis 2006 12 9 14 10.3201/eid1201.051254 16494710 (Pubitemid 43143528)
13. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, Cox NJ, Vaccine 1995 13 1399 1402 10.1016/0264-410X(95)92777-Y 8578816
14. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Rodriguez LL, et al. Vaccine 2003 21 3751 3756 10.1016/S0264-410X(03)00364-5 12922108 (Pubitemid 37338202)
15. Toward a Universal Influenza Virus Vaccine: Prospects and Challenges. Natalie P, Peter P, Annual Review of Medicine 2013 64 189 202 10.1146/annurev-med-120611-145115 23327522
16. Modified M2 proteins produce heterotypic immunity against influenza A virus. Frace AM, Klimov AI, Rowe T, Black RA, Katz JM, Vaccine 1999 17 2237 2244 10.1016/S0264-410X(99)00005-5 10403591 (Pubitemid 29225675)
17. A universal influenza A vaccine based on the extracellular domain of the M2 protein Nat. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, MinJou W, Fiers W, Med. 1999 5 1157 1163 (Pubitemid 29474420)
18. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Okuda K, Ihata A, Watabe S, et al. Vaccine 2001 19 3681 3691 10.1016/S0264-410X(01)00078-0 11395202 (Pubitemid 32522766)
19. Walter Gerhard Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Krystyna M, JinQi F, Mark E, Goran K, Mare C, Laszlo O Jr, Vaccine 2003 21 2616 2626 10.1016/S0264-410X(03)00040-9 12744898 (Pubitemid 36561354)
20. Regulation of pH by the M2 protein of influenza A viruses. Ciampor F, Thompson CA, Grambas S, Hay AJ, Virus Res 1992 22 247 258 10.1016/0168-1702(92) 90056-F 1626420
21. Maturation of influenza A virus hemagglutinin: estimates of the pH encountered during transport and its regulation by the M2 protein. Grambas S, Hay AJ, Virology 1992 190 11 18 10.1016/0042-6822(92)91187-Y 1529523
22. Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2. Mozdzanowska K, Feng J, Eid M, Kragol G, Cudic M, Otvos L Jr, Gerhard W, Vaccine 2003 21 2616 2626 10.1016/S0264-410X(03)00040- 9 12744898 (Pubitemid 36561354)
23. Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006. Yu H, Hua RH, Zhang Q, Liu TQ, Liu HL, Li GX, Tong GZ, J Clin Microbiol 2008 46 1067 1075 10.1128/JCM.01257-07 18199784 (Pubitemid 351380002)
24. Isolation and genetic characterization of avian-like H1N1 and novel ressortant H1N2 influenza viruses from pigs in China. Yu H, Zhang PC, Zhou YJ, Li GX, Pan J, Yan LP, Shi XX, Liu HL, Tong GZ, Biochem Biophys Res Commun 2009 386 278 283 10.1016/j.bbrc.2009.05.056 19460353
25. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM, J Virol 1999 73 5903 5911 10364342 (Pubitemid 29274877)
26. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Wang CY, Chang TY, Walfield AM, Ye J, Shen M, Chen SP, Li MC, Lin YL, Jong MH, Yang PC, Chyr N, Kramer E, Brown F, Vaccine 2002 20 2603 2610 10.1016/S0264-410X(02)00148-2 12057619 (Pubitemid 34615602)
27. Enhanced mucosal immunoglobulin A response and solid protection against foot-and-mouth disease virus challenge induced by a novel dendrimeric peptide. Cubillos C, de la Torre BG, Jakab A, Clementi G, Borras E, Barcena J, Andreu D, Sobrino F, Blanco E, J Virol 2008 82 7223 7230 10.1128/JVI.00401-08 18448530 (Pubitemid 351977739)